Doximity (DOCS) Soars 14% on Strong Earnings, Merger with AI-Powered Platform

We recently published 10 Stocks with Eye-Popping Gains; 5 Jump to New Highs. Doximity Inc. (NYSE:DOCS) is one of the best-performing stocks on Friday.

Doximity Inc. extended its winning streak to a third consecutive day on Friday, jumping 13.71 percent to close at $66.58 apiece as investors continued to load up positions following a strong earnings performance and its increasing adoption of artificial intelligence.

In its updated report, Doximity, Inc. (NYSE:DOCS) registered a net income of $53.3 million in the first quarter of fiscal year 2026, marking a 28-percent growth from the $41.37 million in the same period last year. Revenues grew by 15 percent to $145.9 million from $126.68 million year-on-year.

ESB Professional/Shutterstock.com

For the full fiscal year 2026 period, Doximity, Inc. (NYSE:DOCS) targets to book $628 million to $636 million in revenues, or a 10 to 11.5 percent growth from the $570.4 million registered in full fiscal year 2025. Adjusted EBITDA is also expected to grow between 8.7 and 11.2 percent to $341 million to $349 million, from the $313.8 million posted a year earlier.

Earlier this week, Doximity, Inc. (NYSE:DOCS) announced the completion of its $63 million merger with AI-powered platform Pathway Medical Inc.

According to Doximity, Inc. (NYSE:DOCS), Pathway’s model outperforms others in clinical accuracy, recently scoring a record 96 percent on the US Medical Licensing Examination benchmark.

“There’s a growing need for clinical tools that combine trusted evidence with the speed and adaptability of AI,” said Pathway CEO Jon Hershon. “Hundreds of thousands of users have registered for Pathway, and thousands pay $300 per year for our premium product. With Doximity, one of the most trusted platforms in healthcare, we’re now bringing that experience to millions for free, built directly into the tools they already use at the point of care.”